Can we discontinue statin treatment in post-ACS patients with LDL cholesterol of 70 mg/dl Komentarz

##plugins.themes.bootstrap3.article.main##

Maciej Janiszewski
Marek Kuch

Abstrakt

Post-ACS patients represent a group of patients with the highest cardiovascular risk. In that group, one of the most important aims of therapy is reduction of the LDL-cholesterol to the lowest possible value. Statin use should be mandatory, lifelong, and independent of the baseline lipid parameters.

##plugins.themes.bootstrap3.article.details##

Jak cytować
Janiszewski , M., & Kuch, M. (2016). Can we discontinue statin treatment in post-ACS patients with LDL cholesterol of 70 mg/dl. Medycyna Faktów , 9(1(30), 34-35. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2266
Dział
Artykuły

Bibliografia

1. Reiner Z, Catapano AL, De Backer G et al.; European Association for Cardiovascular Prevention & Rehabilitation. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769-1818.
2. European guidelines on cardiovascular disease prevention in clinical practice (2012). Kardiol Pol 2012; 70(suppl. I): S1-S100.
3. ESC guidelines for the management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Kardiol Pol 2012; 70(suppl. VI): S255-S318.
4. 2015 Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2015 [doi: 10.1093].